more

Agilent Technologies (A)

(Real Time Quote from BATS)

$143.44 USD

-1.53 (-1.06%)

Updated Oct 7, 2024 03:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum F VGM

Industry Rank:

Top 26% (65 out of 252)

Industry: Electronics - Testing Equipment

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

What's in the Offing for Agilent (A) This Earnings Season?

by Zacks Equity Research Published on November 18,2020

Agilent's (A) strength in revenue segments is likely to reflect on fiscal fourth-quarter results. However, the global coronavirus-driven economic crisis may have been a woe.

tech-stocks

Agilent Gets Expanded FDA Approval for pharmDX Assay in U.S.

by Zacks Equity Research Published on November 17,2020

Agilent Technologies (A) gets FDA Approval for PD-L1 IHC 22C3 pharmDx assay, thereby further strengthening presence in the companion diagnostics market.

tech-stocks

Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research Published on November 16,2020

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ANegative Net Change

4 Testing Equipment Stocks to Escape a Challenging Industry

by Zacks Equity Research Published on November 12,2020

Coronavirus-imposed economic turbulences are stressing the Zacks Electronics - Testing Equipment industry. However, industry players like TER, AME, CGNX and NATI are set to gain from 5G prospects.

tech-stocks

Expedia Group's (EXPE) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research Published on November 02,2020

Expedia Group's (EXPE) third-quarter results are expected to reflect benefits from improving travel trends. However, coronavirus woes might have remained headwinds.

Jack Henry (JKHY) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research Published on November 02,2020

Jack Henry's (JKHY) first-quarter fiscal 2021 results are likely to reflect strength across Core, Payments and Complementary segments amid coronavirus woes.

consumer-discretionary

What's in the Cards for MercadoLibre (MELI) in Q3 Earnings?

by Zacks Equity Research Published on November 02,2020

MercadoLibre's (MELI) third-quarter results are likely to reflect benefits from its e-commerce, logistics and fintech offerings.

Why Agilent (A) Could Beat Earnings Estimates Again

by Zacks Equity Research Published on November 02,2020

Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ANegative Net Change

The Truth About Market Timing - October 05, 2020

by Zacks Equity Research Published on October 05,2020

In the long-run, does consistent market timing really matter to be a successful investor?

Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research Published on September 30,2020

Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day

3 Picks to Ride the Coronavirus-Led Strength in Lab Plastic Space

by Urmimala Biswas Published on September 29,2020

These laboratory equipment suppliers' fate does not depend on the end result of the R&D outcomes of the drug and vaccine makers.

medical

Agilent (A) Up 2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research Published on September 17,2020

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ANegative Net Change

The Keys to Successfully Timing the Markets - September 11, 2020

by Zacks Equity Research Published on September 11,2020

In the long-run, does consistent market timing really matter to be a successful investor?

Agilent's (A) Q3 Earnings Beat Estimates, Revenues Down Y/Y

by Zacks Equity Research Published on August 19,2020

Agilent Technologies' (A) fiscal third quarter results reflect growth in pharmaceutical and food market. However, COVID-19 headwinds were concerns.

earnings